Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Mar 20, 2006

Statement responding to recent media reports regarding appropriate use of AMBIEN® (zolpidem tartrate) CIV in the U.S.
Mar 12, 2006

New study furthers understanding of the role of dual antiplatelet therapy in the prevention of atherothrombotic events, including heart attack, stroke or cardiovascular death in broad population

Certain subgroups may benefit from dual therapy, for others it should be avoided
Feb 28, 2006

APIDRA® - a new rapid-acting insulin analog - is now available in the United States for hyperglycemia in adults with type 2 and type 1 diabetes

New prandial insulin with the OptiClik(R) delivery system can work with longer-acting insulins, such as basal insulin Lantus(R), providing a complementary approach to glucose control
Feb 24, 2006

Sanofi-aventis reports strong growth of 25.7% in 2005 adjusted EPS - Nearly 90% of synergies delivered by end 2005 - Dividend increased by 26.7%

Sanofi-aventis Reports Strong Growth of 25.7% in 2005 Adjusted EPS(1); Nearly 90% of synergies delivered by end 2005; Dividend increased by 26.7%
Feb 17, 2006

Sanofi-aventis received from the FDA an approvable letter for rimonabant for weight management and a non approvable letter for smoking cessation
Feb 14, 2006

The Journal of the American Medical Association publishes the RIO-North America study

Study Shows Rimonabant Maintains Improvements in Multiple Cardiometabolic Risk Factors for Up to Two Years
Feb 6, 2006

Sanofi Pasteur Delivers More H5N1 Vaccine for U.S. Government Pandemic Initiatives

New investigational doses include formulation with an adjuvant; Additional stockpile vaccine prepared
Feb 1, 2006

Sanofi Pasteur Experiences Unprecedented U.S. Demand for Influenza Vaccine for 2006-2007 Influenza Season
Jan 30, 2006

Dynamic growth in 2005 full-year consolidated net sales: up 9.3% on a comparable basis
Jan 18, 2006

FDA grants priority review to PLAVIX® (clopidogrel bisulfate) Supplemental New Drug Application (sNDA) for additional type of heart attack

Filing for STEMI Indication Also Submitted in Europe
Jan 13, 2006

Pfizer to purchase Sanofi-aventis rights to EXUBERA® in application of change of control clauses
Jan 4, 2006

Procter & Gamble Pharmaceuticals and Sanofi-aventis US LLC file lawsuit against Roche Pharmaceuticals and Glaxosmithkline

Lawsuit Alleges Advertising for Once-a-Month Osteoporosis Drug Misleads Physicians and Consumers
Dec 13, 2005

PLAVIX® (clopidogrel bisulfate) recommended as effective cardiovascular risk reduction treatment for patients with established Peripheral Arterial Disease (P.A.D.)
Dec 8, 2005

Interim analysis of phase III study shows TAXOTERE®-based regimens with HERCEPTIN® significantly improved disease free survival in women with early-stage HER2-positive breast cancer
Dec 6, 2005

New analysis ranks America’s worst cities for respiratory infections
Dec 2, 2005

FDA Grants Priority Review to Taxotere® for the Supplemental New Drug Application for Advanced Gastric Cancer
Nov 16, 2005

New England Journal of Medicine publishes the RIO-Lipids study
Nov 15, 2005

Study shows that intra-articular hyaluronate therapy HYALGAN® (sodium hyaluronate) is effective in treating chronic shoulder pain due to osteoarthritis
Nov 15, 2005

Analysis from several clinical studies show dronedarone appears to be consistently safe and effective in maintaining normal sinusal rhythm and ventricular rate control in patients with cardiac arrhythmia
Nov 8, 2005

Third quarter 2005: Adjusted EPS up 27.4%, net sales up 11.0% on a comparable basis - First 9 months of 2005: Adjusted EPS up 26.6%, net sales up 11.0% on a comparable basis
Nov 7, 2005

New data show long-term (52 week) use of ALVESCO® (ciclesonide) had a low incidence of oropharyngeal side effects in patients with mild-to-moderate asthma
Oct 20, 2005

EXUBERA® inhaled insulin improves blood sugar levels in adults with type 2 diabetes better than diabetes pills alone
Oct 7, 2005

AMBIEN CR™ now available in the US
Sep 29, 2005

Hearing date set on motion for preliminary injunction in ALLEGRA® (fexofenadine hcl) patent infringement case
Sep 29, 2005

Sanofi-aventis provides relief to hurricane victims

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.